In the field of diagnostics, there has long been a search for solutions to measure low concentrations of small molecules accurately, quickly and easily, for example from food, the environment or a patient sample.
Teijin Pharma and ASKA Pharmaceutical EnterJoint Research Agreement to AccelerateDiscovery of Novel Small-Molecule Drug Candidates for Gynecological Diseases.
Teijin Pharma and Aska Pharmaceutical EnterJoint Research Agreement to AccelerateDiscovery of Novel Small-Molecule Drug Candidates for Gynecological Diseases ... to jointly develop novel small-molecule drug candidates targeting gynecological diseases.
Utilizing its proprietary Artificial Intelligence-assisted Structure-Based Drug Discovery (AISBDD) and Ultra-Long-Acting Platform (ULAP) technologies as well as Peptide Oral Transport ENhancement ...
The Company’s dedicated team of research scientists holds deep expertise in designing innovative small-molecule inhibitors, biologics, targeted protein degraders, multispecific antibodies and antibody drug conjugates.
Machine-learning platform enables signal peptide-informed discovery of small molecules that selectively inhibit protein secretion allowing for the degradation of disease-related proteins at the point of synthesis.